You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 259 No. 12, March 25, 1988 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lithium Treatment of Manic-Depressive Illness

Past, Present, and Perspectives

Mogens Schou, MD

JAMA. 1988;259(12):1834-1836.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

EVEN though the title of this article refers to the past of lithium treatment, I shall spare the reader a lengthy account of its history and instead concentrate more on the situation today and the tasks for tomorrow.

PAST: EFFICACY

It is, however, only appropriate that I mention here the two clinical psychiatrists who have been key figures in the development of lithium treatment: John Cade, MD,1 who in the late 1940s gave lithium to psychiatric patients and discovered its antimanic action, and Poul Christian Baastrup, MD,2,3 who saw and participated in the documentation of its relapse-preventive or prophylactic action against not only manic but also depressive recurrences. Cade and Baastrup were conscientious clinicians who knew their patients well and who had keen observational powers (Figure).

Lithium treatment has gone through a number of developmental phases and crises. They dealt with whether it worked at all or merely . . . [Full Text PDF of this Article]


Author Affiliations

From the Psychopharmacology Research Unit, Århus University Institute of Psychiatry, and the Psychiatric Hospital, Risskov, Denmark.


Footnotes

Based on a lecture given at the presentation of the Albert Lasker Clinical Medical Research Award, New York, Nov18,1987.

Reprint requests to Psykiatrisk Hospital, 2 Skovagervej, 8240 Risskov, Denmark (Dr Schou).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.